respiratori
viral
infect
one
lead
caus
morbid
mortal
particularli
children
elderli
immunocompromis
person
rapid
identif
viral
etiolog
critic
rule
nonvir
infect
initi
antivir
treatment
limit
spread
infect
multiplex
assay
one
viral
gene
target
singl
tube
advantag
rapid
screen
larg
number
potenti
viral
pathogen
short
time
multiplex
realtim
pcr
assay
use
studi
detect
respiratori
rna
dna
viral
infect
specimen
receiv
adult
pediatr
patient
compris
symptomat
asymptomat
organ
transplant
recipi
nonrecipi
diagnosi
respiratori
ill
routin
clinic
monitor
multiplex
pcr
sensit
multiplex
immunofluores
cultur
assay
rmix
also
detect
addit
respiratori
virus
cover
rmix
panel
number
respiratori
virus
detect
symptomat
patient
significantli
higher
asymptomat
patient
adult
pediatr
patient
herpesvir
infect
predomin
caus
lower
respiratori
tract
infect
organ
transplant
recipi
wherea
respiratori
syncyti
viru
common
pathogen
nontranspl
patient
particularli
children
multiplex
realtim
pcr
detect
respiratori
virus
potenti
rapid
identif
viral
pathogen
era
emerg
viral
infect
addit
newer
viral
target
multiplex
pcr
panel
benefici
determin
patient
manag
public
health
epidemiolog
respiratori
viral
infect
one
lead
caus
morbid
mortal
particularli
children
elderli
immunocompromis
person
rapid
identif
viral
etiolog
critic
rule
nonvir
infect
initi
antivir
treatment
limit
spread
infect
multiplex
assay
one
viral
gene
target
singl
tube
advantag
rapid
screen
larg
number
potenti
viral
pathogen
short
time
multiplex
realtim
pcr
assay
use
studi
detect
respiratori
rna
dna
viral
infect
specimen
receiv
adult
pediatr
patient
compris
symptomat
asymptomat
organ
transplant
recipi
nonrecipi
diagnosi
respiratori
ill
routin
clinic
monitor
multiplex
pcr
sensit
multiplex
immunofluores
cultur
assay
rmix
also
detect
addit
respiratori
virus
cover
rmix
panel
number
respiratori
virus
detect
symptomat
patient
significantli
higher
asymptomat
patient
adult
pediatr
patient
herpesvir
infect
predomin
caus
lower
respiratori
tract
infect
organ
transplant
recipi
wherea
respiratori
syncyti
viru
common
pathogen
nontranspl
patient
particularli
children
multiplex
realtim
pcr
detect
respiratori
virus
potenti
rapid
identif
viral
patho
respiratori
viral
infect
respons
spectrum
diseas
sever
rang
mild
uncompl
ill
sever
complic
viral
pneumonia
diseas
sever
affect
variou
host
viral
predispos
factor
age
immunestatu
host
singl
mix
infect
virul
mechan
viral
pathogen
common
respiratori
virus
caus
infect
influenza
b
virus
respiratori
syncyti
viru
rsv
parainfluenza
virus
piv
coronavirus
cov
adenoviru
adv
newli
emerg
respiratori
viral
pathogen
includ
swine
origin
influenza
human
metapneumoviru
hmpv
human
bocaviru
hbov
particularli
pediatr
patient
lu
et
al
dare
et
al
gordon
scalera
mossad
immunocompromis
host
organ
transplant
recipi
often
infect
opportunist
herpesvirus
therefor
rapid
screen
respiratori
viral
pathogen
critic
allow
time
therapeut
decis
limit
pathogenesi
commerci
rapid
viral
cultur
direct
fluoresc
antigen
viral
culturedfa
multiplex
detect
method
rmix
use
commonli
mani
clinic
diagnost
laboratori
includ
respiratori
viral
detect
st
georg
et
al
howev
though
rel
rapid
techniqu
limit
detect
common
respiratori
virus
one
advanc
polymeras
chain
reaction
pcr
assay
multiplex
realtim
pcr
allow
detect
multipl
rna
dna
target
singl
tube
van
elden
et
al
studi
multiplex
realtim
pcr
assay
develop
target
respiratori
rna
dna
virus
assess
util
rapid
molecular
screen
tool
clinic
diagnosi
assay
varieti
respiratori
virus
caus
symptomat
asymptomat
infect
identifi
organ
transplant
nonorgan
transplant
adult
pediatr
patient
concurr
prospect
studi
approv
univers
pittsburgh
institut
review
board
decemb
residu
respiratori
specimen
receiv
viral
culturedfa
univers
pittsburgh
medic
center
clinic
virolog
laboratori
store
lysi
buffer
nucleic
acid
isol
multiplex
pcr
test
total
specimen
collect
adult
pediatr
patient
organ
transplant
recipi
clinic
inform
patient
collect
correl
laboratori
data
upper
respiratori
tract
infect
defin
clinic
symptom
rhinorrhea
sore
throat
cough
without
fever
without
evid
dyspnea
abnorm
chest
xray
lower
respiratori
tract
infect
defin
presenc
dyspnea
clinic
evid
pulmonari
patholog
chest
xray
along
fever
cough
machado
et
al
patient
present
without
appar
respiratori
symptom
defin
asymptomat
latter
specimen
obtain
organ
transplant
recipi
routin
surveil
cultur
pediatr
age
group
includ
specimen
neonat
week
children
year
age
prequantit
influenza
influenza
b
virus
human
cytomegaloviru
cmv
human
herpesviru
dna
obtain
advanc
biotechnolog
columbia
md
coronavirus
known
tcid
titer
purchas
atcc
manassa
va
clinic
isol
adv
rsv
herp
simplex
viru
deriv
clinic
virolog
laboratori
titer
tissu
cultur
infecti
dose
tcid
reed
muench
plasmid
construct
hbov
dna
kindli
provid
dr
dean
erdman
cdc
atlanta
ga
hmpv
rna
gener
laboratori
previous
describ
dare
et
al
isol
viral
nucleic
acid
control
materi
patient
specimen
done
use
easymag
autom
extractor
durham
nc
accord
manufactur
instruct
briefli
ml
specimen
mix
lysi
buffer
biomerieux
min
fix
volum
concentr
equin
arter
viru
eav
tcid
ml
ad
intern
control
rna
extract
amplif
follow
addit
magnet
silica
per
manufactur
instruct
nucleic
acid
elut
ml
elut
volum
store
process
multiplex
onestep
pcr
perform
six
panel
shown
tabl
previous
publish
virusspecif
primer
probe
nucleotid
sequenc
use
hmpv
eav
intern
control
hbov
locatelli
et
al
balasuriya
et
al
templeton
et
al
van
elden
et
al
kuyper
et
al
lu
et
al
dare
et
al
sanghavi
et
al
influenza
influenza
b
influenza
influenza
primer
probe
sequenc
avail
cdc
laboratori
respons
network
http
wwwbtcdcgov
lrn
probe
label
either
cal
fluor
red
quasar
report
dye
biosearch
technolog
novato
ca
primer
probe
sequenc
shown
tabl
pcr
reaction
consist
ml
volum
ml
quantitect
multiplex
rtpcr
nr
master
mix
rtenzym
rna
viral
target
quantitect
multiplex
pcr
nr
master
mix
dna
viral
target
qiagen
valencia
ca
concentr
primer
probe
viral
target
panel
optim
sensit
shown
tabl
multiplex
pcr
reaction
mix
supplement
mlreaction
amplitaq
gold
dna
polymeras
pcr
thermal
cycl
condit
rna
pcr
optim
follow
condit
min
revers
transcript
min
cycl
sec
min
pcr
thermal
cycl
condit
dna
pcr
min
min
cycl
min
min
detect
perform
use
abi
realtim
pcr
instrument
appli
biosystem
foster
citi
ca
two
rmix
shell
vial
contain
mix
monolay
mink
lung
cell
strain
human
adenocarcinoma
cell
strain
inocul
cmv
cultur
stain
steril
onedram
vial
contain
human
lung
fibroblast
cell
coverslip
dhi
use
describ
st
georg
rinaldo
briefli
vial
inocul
ml
prepar
sampl
centrifug
incub
incub
coverslip
wash
fix
cell
monolay
stain
ml
anticmv
monoclon
antibodi
millipor
billerica
counterstain
fluorescein
isothiocyanatelabel
goat
antimous
immunoglobulin
g
conjug
evan
blue
dye
bartel
triniti
biotech
jamestown
ny
posit
sampl
exhibit
appl
green
fluores
detail
nuclei
cmv
hsv
cultur
tube
contain
human
fetal
lung
fibroblast
mrhf
human
foreskin
fibroblast
human
lung
carcinoma
cell
use
dhi
tube
inocul
ml
prepar
sampl
place
horizont
posit
incub
adsorpt
step
min
inoculum
remov
tube
fed
fresh
mainten
media
eagl
minimum
essenti
medium
fetal
bovin
serum
tube
cultur
return
horizont
posit
incub
observ
cytopath
effect
cpe
hr
day
postinocul
hsv
cultur
observ
characterist
cpe
round
balloon
cell
without
syncytia
student
ttest
use
determin
statist
signific
p
assay
perform
sensit
determin
use
serial
dilut
known
quantiti
virus
viral
rna
sensit
target
multiplex
pcr
assay
similar
obtain
singleplex
pcr
individu
viral
target
lower
limit
detect
multiplex
pcr
follow
influenza
viral
particl
unit
per
millilit
vpuml
influenza
b
vpuml
rsv
tcid
ml
tcid
ml
tcid
ml
tcid
ml
hcov
tcid
ml
hcov
tcid
ml
adv
tcid
ml
tcid
ml
hmpv
rna
copiesml
cmv
dna
copiesml
dna
copiesml
hbov
dna
copyml
amplif
specif
target
viral
gene
nonspecif
amplif
observ
test
virus
panel
panel
well
randomli
select
pcr
positivermix
neg
discrep
specimen
confirm
dna
sequenc
purifi
pcr
product
addit
altern
multiplex
nucleic
acid
detect
kit
multicodeplx
system
eragen
bioscienc
madison
wi
use
luminex
austin
tx
detect
platform
use
assay
specimen
parallel
multiplex
pcr
assay
eragen
assay
detect
influenza
influenza
b
rsv
hcov
hcov
hcov
adv
hmpv
rhinoviru
multiplex
pcr
assay
detect
five
influenza
one
influenza
b
rsv
two
four
three
hmpv
one
five
cov
seven
adv
specimen
multiplex
pcr
also
detect
one
rsv
one
six
hmpv
two
five
adv
posit
specimen
miss
detect
one
infect
compar
eragen
assay
studi
compris
adult
n
pediatr
n
patient
popul
total
specimen
collect
total
patient
patient
stem
cell
solid
organ
transplant
recipi
adult
pediatr
remain
patient
undergo
organ
transplant
adult
pediatr
compris
hospit
patient
outpati
among
organ
transplant
recipi
specimen
lung
transplant
n
follow
stem
cell
transplant
n
recipi
clinic
symptom
rang
asymptomat
mild
upper
respiratori
tract
infect
sever
lower
respiratori
tract
infect
multiplex
pcr
sensit
rmix
also
detect
addit
respiratori
virus
includ
rmix
panel
tabl
ii
total
posit
multiplex
pcr
detect
posit
rmix
addit
viral
infect
cover
rmix
cultur
among
commun
acquir
viral
infect
rsv
n
common
etiolog
agent
follow
adv
n
influenza
viru
n
influenza
viru
posit
test
human
influenza
strain
subtyp
two
posit
among
respiratori
virus
cover
rmix
signific
infect
caus
hmpv
cov
recent
identifi
hbov
cmv
detect
frequent
organ
transplant
recipi
clinic
signific
viral
infect
determin
analyz
clinic
data
symptomat
asymptomat
patient
adult
organ
transplant
recipi
cmv
found
significantli
associ
lower
respiratori
tract
infect
tabl
iii
surprisingli
group
rsv
also
found
strong
associ
upper
lower
respiratori
tract
infect
influenza
viru
adv
also
caus
signific
infect
organ
transplant
recipi
nontranspl
recipi
adult
patient
addit
influenza
viru
rsv
adv
hmpv
cov
significantli
associ
mild
sever
respiratori
infect
cmv
also
significantli
associ
symptomat
respiratori
infect
appar
immunocompet
adult
contrast
adult
patient
popul
herpesvirus
cmv
associ
respiratori
infect
transplant
nontranspl
recipi
pediatr
patient
nontranspl
recipi
commun
acquir
virus
influenza
viru
rsv
hbov
predomin
etiolog
agent
respiratori
infect
none
significantli
associ
respiratori
infect
organ
transplant
recipi
tabl
iii
specimen
test
dual
viral
infect
detect
specimen
tabl
iv
tripl
viral
infect
found
specimen
data
shown
coinfect
associ
rsv
adv
n
cmv
n
rsv
cmv
n
tripl
infect
n
common
among
adult
transplant
recipi
data
shown
respiratori
infect
one
major
caus
morbid
mortal
newli
emerg
respiratori
viral
infect
viral
etiolog
go
undetect
either
due
lack
assay
sensit
limit
number
virus
detect
convent
method
freymuth
et
al
studi
use
inhous
multiplex
realtim
pcr
assay
evalu
diagnost
tool
rapid
detect
viral
respiratori
tract
infect
correl
find
clinic
symptom
viral
cultur
multiplex
pcr
assay
sever
advantag
convent
viral
culturedfa
rmix
tube
cultur
detect
method
first
similar
studi
kim
et
al
murali
et
al
multiplex
pcr
detect
virus
viral
culturedfa
sensit
multiplex
pcr
found
compar
singleplex
pcr
individu
virus
higher
viral
culturedfa
detect
reason
higher
sensit
pcr
detect
lower
titer
viral
genom
well
virus
replic
compet
liolio
et
al
second
virus
includ
rmix
cultur
panel
hmpv
hbov
hcov
could
also
detect
multiplex
pcr
assay
sinc
studi
carri
emerg
swineorigin
influenza
viru
pandem
multiplex
pcr
includ
primer
target
howev
multiplex
pcr
assay
modifi
detect
swineorigin
influenza
found
highli
sensit
specif
detect
three
predomin
influenza
virus
use
lower
number
respiratori
viral
infect
note
immunocompet
compar
immunocompromis
adult
suggest
respiratori
viral
infect
immunocompromis
patient
differ
immunocompet
patient
higher
viral
replic
lead
increas
viral
shed
leung
et
al
camp
serra
et
al
compar
studi
templeton
et
al
hindiyeh
et
al
multiplex
pcr
rel
lower
sensit
howev
respiratori
viral
infect
detect
symptomat
group
asymptomat
immunocompet
adult
indic
true
activ
infect
overal
posit
rate
multiplex
pcr
compar
report
other
gadsbi
et
al
among
posit
symptomat
patient
asymptomat
patient
signific
associ
also
observ
symptomat
respiratori
ill
posit
viral
detect
adult
patient
compris
immunocompromis
organ
transplant
recipi
pediatr
patient
mostli
nonorgan
transplant
recipi
respiratori
complaint
spectrum
viral
isol
differ
adult
pediatr
patient
well
organ
transplant
nontranspl
recipi
herpesvir
infect
cmv
predomin
adult
organ
transplant
recipi
wherea
rsv
present
predominantli
pediatr
nontranspl
patient
opportunist
herpesvirus
also
associ
significantli
lower
respiratori
tract
infect
nonorgan
transplant
recipi
appar
immunocompet
host
signific
herpesvir
infect
known
caus
lifelong
latentreactiv
infect
need
evalu
detect
rna
transcript
andor
antigen
determin
viral
load
use
quantit
pcr
virus
help
detect
replic
virus
herpesvirus
report
previous
caus
pneumon
immunocompet
adult
underli
role
communityacquir
pneumonia
karakelid
et
al
merk
et
al
rafailidi
et
al
present
studi
rsv
also
significantli
associ
symptomat
respiratori
infect
organ
transplant
recipi
rsv
commun
viral
infect
report
import
caus
morbid
mortal
immunocompromis
transplant
recipi
muir
pillay
nichol
et
al
therefor
possibl
convent
viral
culturedfa
rmix
method
miss
detect
virus
caus
sever
infect
immunocompromis
immunocompet
patient
advantag
pcrbase
assay
detect
coinfect
two
respiratori
virus
usual
miss
viral
culturedfa
rmix
rang
multipl
infect
report
guittet
et
al
clinic
signific
infect
well
understood
one
plausibl
reason
could
residu
persist
viral
nucleic
acid
particularli
viral
dna
past
infect
codetect
highli
sensit
multiplex
pcr
assay
present
studi
rsv
found
associ
often
coinfect
commun
acquir
viral
infect
suggest
rsvassoci
dual
infect
usual
lead
increas
sever
clinic
ill
aberl
et
al
adult
organ
transplant
recipi
cmv
dual
infect
tripl
infect
cmv
detect
commonli
detail
studi
includ
viru
quantit
requir
determin
clinic
signific
multipl
viral
infect
